FGF9 and myocardial infarction: Moreover, FGF-9 treated post-MI hearts show an increase in number of c-Kit+ve/CD31+ve cells was significantly enhanced in both nondiabetic and diabetic mice compared to sham operated mice (p < 0.05, Figure 4(b)).